“…Clark et al [18] found that an endometrial biopsy result showing cancer was more accurate at ruling in disease than a negative test result was at ruling it out, with a post test probability of 81.7% for a positive result and 0.9% for a negative result. 18 Bansal et al reported that the overall ability of preoperative endometrial sampling to detect a malignancy was significantly lower for non-endometrioid histologies with 75% accuracy for uterine papillary serous and clear cell carcinomas, 59% for carcinosarcoma, and 52% for other sarcomas [19]. Sany et al [20] described a correlation between underlying histology and the ability to make an accurate diagnosis based on preoperative endometrial sampling (endometroid carcinoma 78%, nonendometrioid carcinoma 67%, carcinosarcoma 90%, and sarcoma 40%) [20].…”